Published in Obesity and Diabetes Week, August 9th, 2004
The new agreement must be approved by a federal judge after some details are ironed out over the next couple weeks. It would affect about 41,600 former users of the diet drugs Pondimin and Redux who suffered moderate heart valve damage.
Wyeth pulled the drugs, part of the once wildly popular fen-phen combination, from the market in September 1997 amid reports they had caused heart valve damage and, in a small number of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week